{"slug":"selank-chemo-neuropathy","verification":{"valid":true,"entries":1,"head":"1db129b5e2782a28067fdd267a48acbe35a960ecf1932e75ff74f916174bc83d"},"count":1,"models":["grok/grok-4.3"],"yield":{"passes":1,"energy_spent_rows":0,"total_cost_usd":0.026874,"waste_cost_usd":0,"total_tokens":18795,"material_outputs":0,"usd_per_output":null,"models":[{"model":"grok/grok-4.3","passes":1,"cost_usd":0.026874,"tokens_total":18795,"outputs":0,"waste_passes":0,"usd_per_output":null}],"constraints":{"constitution":"/api/articles/constitution","collaborate_schema":"POST /api/protocol/collaborate","pricing_ppm":{"grok-4.3":[1.25,2.5],"grok/grok-4.3":[1.25,2.5],"grok-build-0.1":[1,2],"kimi/moonshot-v1-8k":[0.15,0.15],"gemini/gemini-2.5-flash":[0.075,0.3],"gemini/gemini-2.0-flash-lite":[0.075,0.3],"openai/gpt-4o":[2.5,10],"openai/gpt-4o-mini":[0.15,0.6],"system/reflex":[0,0],"ingest:deterministic":[0,0],"fill-slots":[0,0]}}},"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:47:05.102Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer","register":"source_ledger","body":"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy (CIPN) involves damage to peripheral nerves from agents like taxanes, platinums, and vinca alkaloids. This produces sensory symptoms such as burning pain, tingling, numbness, and loss of proprioception, often in a stocking-glove distribution. Nerve fibers undergo axonal degeneration and demyelination. Inflammatory signaling and oxidative stress contribute to ongoing nerve dysfunction. Chronic stress and heightened anxiety states can amplify pain perception and interfere with sleep, which in turn affects nerve repair processes. The condition persists when degenerative processes outpace any natural regenerative capacity of the nerves.\n\n## Why Selank might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, non-restorative arousal, and anxiety that can worsen perceived neuropathic symptoms.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n**Therefore for you:** This drug suppresses a signal. It may reduce symptom intensity enough to improve daily function and sleep, but it does not address underlying nerve damage or support regeneration. Any benefit trades off symptom control for potential side effects without advancing repair pathways.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Selank** → anxiety / neurochemistry\n\nSelank is examined specifically for the anxiety and neurochemistry layer that can compound CIPN symptoms. Gabapentin or pregabalin addresses symptomatic signal suppression. The two operate on separate layers: one potentially supporting neurochemical balance, the other providing temporary signal dampening. No direct interaction data exists for this pairing in CIPN.\n\n## What the evidence actually shows\n\nNo published studies examine Selank in CIPN or chemotherapy-related nerve damage. Human data on Selank come from Russian trials focused on generalized anxiety disorder (GAD). One study of 62 patients compared Selank to medazepam and reported comparable anxiolytic effects on psychometric scales without sedation or dependence. Another small trial of 30 patients noted similar efficacy to benzodiazepines plus some cognitive enhancement. These are tiered human. Rat studies show Selank modulates GABA receptor expression and reduces anxiety-like behaviors in stress models, tiered preclinical. No human or animal data link Selank directly to nerve regeneration, axonal repair, or CIPN models.\n\n## What scientists say\n\nResearchers describe Selank as producing anxiolytic and nootropic effects through influences on GABA_A receptors and possible cytokine modulation. Russian clinical literature notes its use in anxiety disorders with fewer side effects than benzodiazepines. Western reviews highlight the limited number of independent replications and absence of large-scale international RCTs. No statements appear in CIPN guidelines or reviews regarding Selank.\n\n## What people say on Reddit\n\nAnecdotal reports on Reddit discuss Selank mainly for general anxiety or cognitive support, not CIPN. Users describe subjective calm without sedation. No threads specifically tie Selank use to chemotherapy neuropathy symptoms. These remain anecdotal.\n\n## What people say on X\n\nPosts on X mention Selank in contexts of anxiety relief or peptide research. Occasional references note Russian origin and anxiolytic properties. No documented user experiences link Selank to CIPN improvement. These stay anecdotal.\n\n## What we do not know\n\nDirect evidence for Selank in CIPN is absent. It is unknown whether Selank affects nerve inflammation, axonal transport, or mitochondrial function in chemotherapy-damaged nerves. Long-term human safety data outside Russian anxiety trials is limited. Interactions with chemotherapy agents or standard CIPN treatments remain unstudied. Any extension to neuropathy rests on mechanistic extrapolation from anxiety data.\n\n## Safety and limits\n\nSelank shows a favorable short-term profile in available human anxiety studies, with reports of minimal sedation or withdrawal. No CIPN-specific safety data exist. All discussion here is evidence grading only; nothing constitutes medical advice or treatment recommendation.","claims":[{"id":"c1","text":"No published studies examine Selank in CIPN.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the primary topic.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:47:04.713Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Human trials show Selank has anxiolytic effects comparable to low-dose benzodiazepines in GAD without sedation or dependence.","section":"What the evidence actually shows","tier":"human","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Provides the actual human data tier for Selank.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:47:04.713Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Rat studies demonstrate Selank modulates GABA_A receptors and reduces anxiety-like behaviors.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Separates preclinical from human evidence.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:47:04.713Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Gabapentinoids show limited and inconsistent evidence for CIPN treatment; no significant benefit in prevention meta-analysis.","section":"Why Gabapentin / pregabalin matters for you","tier":"human","source_ids":["s5"],"source_status":"sourced","why_material":"Grades the drug evidence accurately.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:47:04.713Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic, and Noradrenergic Neurotransmission","quote":"Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/25176261/","title":"A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders in non-psychotic patients","quote":"Selank provided significant improvement of life quality in patients without noticeable side effects.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/","title":"Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats","quote":"Selank has a pronounced anxiolytic activity...","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":16091,"tokens_out":2704,"cost":0.02687375,"prev_hash":"genesis","hash":"1db129b5e2782a28067fdd267a48acbe35a960ecf1932e75ff74f916174bc83d"}]}